MicuRx Pharmaceuticals and Cumencor Pharmaceuticals Partner with Pfizer to Discover and Develop Antibiotics for Drug-Resistant Tuberculosis in China

We first read this post at FierceBiotech.com.

New Vaccines Against Tuberculosis Needed for Prevention and Control

Derived from the works of Paul-Henri Lambert, Tony Hawkridge, Willem A. Hanekom
Clinics in Chest Medicine, 2009, vol 3. (4) pp. 811-26

The Week in TB R&D – 27 April 2010

how much does the nose know? — How much does the nose know about TB?

North America’s Sole Manufacturer of MDR-TB Drugs Closing Its Doors

This post originally appeared at http://www.news25.us/Global/story.asp?S=12380174

Latest Issue of Stop TB News Monitor Available

Register Now for Open Forum 4: Key Issues in TB Drug Development

Open Forum 4 Banner — Open Forum 4: Key Issues in TB Drug Development

An Interview with Dr. Dennis Mitchison: Part Three of a Three Part Series

This week in TB R&D – 20 April 2010

Despite the massive need for new TB drugs, the commercial viability of the TB drug market has long been viewed as questionable at best. Reports suggest that there is a substantial market that will grow year-over-year, though there is no firm conclusion about its commercial viability.

UNAIDS Poll on the Impact of the Economic Crisis on HIV Programs

UNAIDS is conducting a second-round assessment on the impact of the financial crisis on HIV treatment and prevention programmes. The first assessment was carried out in August 2009. Its findings were reflected in the report “Update on the impact of the economic crisis: HIV Prevention and Treatment Programmes” that can be accessed at the following link http://data.unaids.org/pub/Report/2010/economiccrisisandhivandaids61_en.pdf

New Edition of WHO TB Treatment Guidelines

world health organization — World Health Organization

MicuRx Pharmaceuticals and Cumencor Pharmaceuticals Partner with Pfizer to Discover and Develop Antibiotics for Drug-Resistant Tuberculosis in China

New Vaccines Against Tuberculosis Needed for Prevention and Control

The Week in TB R&D – 27 April 2010

North America’s Sole Manufacturer of MDR-TB Drugs Closing Its Doors

Latest Issue of Stop TB News Monitor Available

Register Now for Open Forum 4: Key Issues in TB Drug Development

An Interview with Dr. Dennis Mitchison: Part Three of a Three Part Series

This week in TB R&D – 20 April 2010

UNAIDS Poll on the Impact of the Economic Crisis on HIV Programs

New Edition of WHO TB Treatment Guidelines

Pages

About Us

Navigate

Contact

Follow Us